CIK: 0001952142
Total reported value
$522.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax Sa-adr | Stock-Other | 9.06% | -2.37% | +135.63% | |
| 2 | SRRK | Scholar Rock Holding CORP | Stock-Other | 6.78% | +3.08% | +56.31% | |
| 3 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 4.95% | -4.95% | EXIT | |
| 4 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 4.83% | — | -8.65% | |
| 5 | GPCR | Structure Therapeutics INC | Stock-Other | 4.19% | -2.34% | +171.44% | |
| 6 | ACLXGBX | Arcellx INC | Stock-Other | 3.72% | -3.72% | EXIT | |
| 7 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 3.60% | -1.55% | -76.97% | |
| 8 | 430 | Terns Pharmaceuticals INC | Stock-Other | 2.97% | -2.97% | +378.92% | |
| 9 | TWST | Twist Bioscience CORP | Stock-Other | 2.82% | -2.43% | — | |
| 10 | IMVT | Immunovant INC | Stock-Other | 2.81% | — | -64.94% | |
| 11 | DYN | Dyne Therapeutics INC | Stock-Other | 2.80% | -1.04% | +75.98% | |
| 12 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 2.68% | -1.11% | +81.29% | |
| 13 | SRZN | Surrozen INC | Stock-Other | 2.17% | — | -13.13% | |
| 14 | CELC | Celcuity INC | Stock-Other | 2.02% | -0.71% | -13.44% | |
| 15 | MLYS | Mineralys Therapeutics INC | Stock-Other | 1.80% | +0.97% | +83.45% | |
| 16 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 1.77% | -1.77% | EXIT | |
| 17 | ADPT | Adaptive Biotechnologies | Stock-Other | 1.69% | -1.69% | EXIT | |
| 18 | PALI | Palisade Bio INC | Stock-Other | 1.69% | -1.69% | EXIT | |
| 19 | CYTK | Cytokinetics INC | Stock-Healthcare | 1.60% | — | — | |
| 20 | EWTX | Edgewise Therapeutics INC | Stock-Other | 1.54% | — | — | |
| 21 | DRUG | Bright Minds Biosciences INC | Stock-Other | 1.30% | -1.30% | EXIT | |
| 22 | NKTR | Nektar Therapeutics | Stock-Other | 1.29% | -1.29% | EXIT | |
| 23 | JNJ | Johnson & Johnson | Stock-Healthcare | 1.24% | — | — | |
| 24 | DNLI | Denali Therapeutics INC | Stock-Other | 1.19% | — | -75.84% | |
| 25 | AMLX | Amylyx Pharmaceuticals INC | Stock-Other | 1.17% | — | +104.11% | |
| 26 | CLPT | Clearpoint Neuro INC | Stock-Other | 1.13% | -1.13% | EXIT | |
| 27 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 1.12% | — | -45.44% | |
| 28 | EYPT | Eyepoint INC | Stock-Other | 1.11% | +0.89% | — | |
| 29 | ✓ | Immatics NV | Stock-Other | 1.10% | -1.10% | EXIT | |
| 30 | OCUL | Ocular Therapeutix INC | Stock-Other | 1.09% | -1.09% | EXIT | |
| 31 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 1.08% | -1.08% | EXIT | |
| 32 | PRAX | Praxis Precision Medicines I | Stock-Other | 1.06% | +2.41% | — | |
| 33 | APGE | Apogee Therapeutics INC | Stock-Other | 1.04% | -1.04% | EXIT | |
| 34 | INCY | Incyte CORP | Stock-Healthcare | 1.04% | -1.04% | EXIT | |
| 35 | IDYA | Ideaya Biosciences INC | Stock-Other | 0.96% | -0.96% | EXIT | |
| 36 | ASMB | Assembly Biosciences INC | Stock-Other | 0.91% | — | +137.00% | |
| 37 | MAZE | Maze Therapeutics INC | Stock-Other | 0.89% | -0.89% | EXIT | |
| 38 | PTGX | Protagonist Therapeutics INC | Stock-Other | 0.89% | — | +23.93% | |
| 39 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.88% | -0.88% | EXIT | |
| 40 | TRVI | Trevi Therapeutics INC | Stock-Other | 0.86% | -0.86% | EXIT | |
| 41 | RVMD | Revolution Medicines INC | Stock-Healthcare | 0.85% | +4.49% | -66.54% | |
| 42 | VRDN | Viridian Therapeutics INC | Stock-Other | 0.82% | -0.82% | EXIT | |
| 43 | ABUS | Arbutus Biopharma CORP | Stock-Other | 0.81% | -0.81% | EXIT | |
| 44 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 0.79% | -0.79% | EXIT | |
| 45 | CTMX | Cytomx Therapeutics INC | Stock-Other | 0.76% | -0.76% | EXIT | |
| 46 | XFOR | X4 Pharmaceuticals INC | Stock-Other | 0.62% | — | +61.77% | |
| 47 | WHWK | Whitehawk Therapeutics INC | Stock-Other | 0.61% | — | +243.99% | |
| 48 | DNTH | Dianthus Therapeutics INC | Stock-Other | 0.56% | — | +91.59% | |
| 49 | ASND | Ascendis Pharma A/S | Stock-Other | 0.54% | — | -2.03% | |
| 50 | RGEN | Repligen CORP | Stock-Healthcare | 0.44% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ABVX | Abivax Sa-adr | +6.2% | +135.63% | Add |
| 2 | ACLXGBX | Arcellx INC | +3.5% | +2825.98% | Add |
| 3 | GPCR | Structure Therapeutics INC | +3.5% | +171.44% | Add |
| 4 | 430 | Terns Pharmaceuticals INC | +2.8% | +378.92% | Add |
| 5 | DYN | Dyne Therapeutics INC | +1.6% | +75.98% | Add |
| 6 | 260 | Centessa Pharmaceuticals-adr | +1.6% | +48.46% | Add |
| 7 | SRRK | Scholar Rock Holding CORP | +1.4% | +56.31% | Add |
| 8 | XENE | Xenon Pharmaceuticals INC | +1.1% | +81.29% | Add |
| 9 | CLPT | Clearpoint Neuro INC | +1.1% | +2793.87% | Add |
| 10 | MDGL | Madrigal Pharmaceuticals INC | +1% | +116.11% | Add |
| 11 | NKTR | Nektar Therapeutics | +0.7% | +235.10% | Add |
| 12 | CELC | Celcuity INC | +0.7% | -13.44% | Trim |
| 13 | ABUS | Arbutus Biopharma CORP | +0.6% | +228.49% | Add |
| 14 | SNDX | Syndax Pharmaceuticals INC | +0.6% | -8.65% | Trim |
| 15 | MLYS | Mineralys Therapeutics INC | +0.6% | +83.45% | Add |
| 16 | RVMD | Revolution Medicines INC | -0.9% | -66.54% | Trim |
| 17 | IDYA | Ideaya Biosciences INC | -1.1% | -56.52% | Trim |
| 18 | VTGN | Vistagen Therapeutics INC | -1.5% | -75.22% | Trim |
| 19 | IMVT | Immunovant INC | -2.3% | -64.94% | Trim |
| 20 | DNLI | Denali Therapeutics INC | -3.9% | -75.84% | Trim |
| 21 | QURE | uniQure N.V. | -5.9% | -91.67% | Trim |
| 22 | ROIV | Roivant Sciences Ltd. | -9.1% | -76.97% | Trim |
| 23 | BHVN | Biohaven Ltd. | — | EXIT | Sold out |
| 24 | TWST | Twist Bioscience CORP | — | NEW | New buy |
| 25 | WVE | Wave Life Sciences Ltd. | — | EXIT | Sold out |
| 26 | CDTX | Cidara Therapeutics INC | — | EXIT | Sold out |
| 27 | ADPT | Adaptive Biotechnologies | — | NEW | New buy |
| 28 | PALI | Palisade Bio INC | — | NEW | New buy |
| 29 | CYTK | Cytokinetics INC | — | NEW | New buy |
| 30 | ARGX | Argenx Se - Adr | — | EXIT | Sold out |
| 31 | EWTX | Edgewise Therapeutics INC | — | NEW | New buy |
| 32 | RZLT | Rezolute INC | — | EXIT | Sold out |
| 33 | GHRS | GH Research PLC | — | EXIT | Sold out |
| 34 | DRUG | Bright Minds Biosciences INC | — | NEW | New buy |
| 35 | ALKS | Alkermes plc | — | EXIT | Sold out |
| 36 | JNJ | Johnson & Johnson | — | NEW | New buy |
| 37 | BBIO | Bridgebio Pharma INC | — | EXIT | Sold out |
| 38 | EYPT | Eyepoint INC | — | NEW | New buy |
| 39 | ✓ | Immatics NV | — | NEW | New buy |
| 40 | INSM | Insmed INC | — | EXIT | Sold out |
| 41 | PRAX | Praxis Precision Medicines I | — | NEW | New buy |
| 42 | APGE | Apogee Therapeutics INC | — | NEW | New buy |
| 43 | AKRO | Akero Therapeutics INC | — | EXIT | Sold out |
| 44 | MAZE | Maze Therapeutics INC | — | NEW | New buy |
| 45 | JAZZ | Jazz Pharmaceuticals plc | — | EXIT | Sold out |
| 46 | LLY | Eli Lilly & Co | — | NEW | New buy |
| 47 | RNAGBP | Avidity Biosciences INC | — | EXIT | Sold out |
| 48 | VRDN | Viridian Therapeutics INC | — | NEW | New buy |
| 49 | MLTX | Moonlake Immunotherapeutics | — | NEW | New buy |
| 50 | CTMX | Cytomx Therapeutics INC | — | NEW | New buy |